An experimental drug that can virtually halt the deadly spread of breast cancer has been tested by scientists.
Researchers are now working with a biotechnology company to prepare the compound for patient trials.
The new research builds on previous studies of a gene called Bc13 that appears to play a critical role in the spread of breast cancer.
Scientists at Cardiff University conducted computer simulations to work out how Bc13 functioned and then blocked it.
In tests on mice, the researchers first deleted the gene and then explored ways of inhibiting it with a drug.They found the right candidate compound by screening a library of chemicals until one was found that could target Bc13.
When mice with metastatic breast cancer were treated with the compound, the spread of tumours to the lungs and other parts of the body was dramatically reduced.
More top news
The number of terminal cancer patients who die in hospital rather than at home is placing "unnecessary strain" on the NHS, a report says.
Half of police forces in England and Wales do not have the capability and resources to tackle corruption among officers, a new report says.
There is a snow and ice warning in force for much of the UK tomorrow, but temperatures will be slightly higher than today.